Milestone Scientific Inc. Receives Notice of Allowance for U.S Patent Related to CompuFlo® Disposables
January 20 2021 - 3:00PM
Milestone Scientific Inc. (NYSE American:MLSS), a
leading developer of computerized drug delivery instruments that
provides virtually painless and precise injections, today announced
that it has received a Notice of Allowance from the United States
Patent and Trademark Office (USPTO) for a patent relating to the
disposable component of Milestone’s CompuFlo® Instrument.
Dr. Mark Hochman, D.D.S., Inventor and Clinical Director for
Milestone Scientific, commented, "Our clinical objectives have
always been to focus on creating greater control and safety of our
disposables. This aligns with our commercial strategy to ensure our
disposables are protected due to the high margin, recurring revenue
nature of these sales. This patent will cover the unique
interactions of the disposable assembly and a micro-chip security
verification feature embedded in the disposables, which provides
numerous clinical and safety benefits for the patient and
practitioner. This patent also covers the use of an embedded
security chip, which is intended to enhance the safety and
integrity of our system by preventing improper reuse of the
disposables, as well as ensuring our instrument can only be used
with authenticated disposables for the current and future systems.
Ensuring the use of only authorized disposable components is
critical to CompuFlo’s performance, safety as well as our long-term
financial success of the Company. I am proud to state that we
currently hold more than 20 patents surrounding our injection and
drug delivery systems, which further solidifies our leadership
position in this market.”
About Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS) is a biomedical
technology research and development company that patents, designs
and develops innovative diagnostic and therapeutic injection
technologies and instruments for medical, dental, cosmetic and
veterinary applications. Milestone's computer-controlled systems
are designed to make injections precise, efficient, and virtually
painless. Milestone’s proprietary DPS Dynamic Pressure Sensing
technology® is our technology platform that advances the
development of next-generation devices, regulating flow rate and
monitoring pressure from the tip of the needle, through platform
extensions for local anesthesia for subcutaneous drug delivery,
with specific applications for cosmetic botulinum toxin injections,
epidural space identification in regional anesthesia procedures and
intra-articular joint injections. For more information please visit
our website: www.milestonescientific.com.
Safe Harbor Statement
This press release contains forward-looking
statements regarding the timing and financial impact of Milestone's
ability to implement its business plan, expected revenues, timing
of regulatory approvals and future success. These statements
involve a number of risks and uncertainties and are based on
assumptions involving judgments with respect to future economic,
competitive and market conditions, future business decisions and
regulatory developments, all of which are difficult or impossible
to predict accurately and many of which are beyond Milestone's
control. Some of the important factors that could cause actual
results to differ materially from those indicated by the
forward-looking statements are general economic conditions, failure
to achieve expected revenue growth, changes in our operating
expenses, adverse patent rulings, FDA or legal developments,
competitive pressures, changes in customer and market requirements
and standards, and the risk factors detailed from time to time in
Milestone's periodic filings with the Securities and Exchange
Commission, including without limitation, Milestone's Annual Report
for the year ended December 31, 2019. The forward-looking
statements in this press release are based upon management's
reasonable belief as of the date hereof. Milestone undertakes no
obligation to revise or update publicly any forward-looking
statements for any reason.
Contact:David Waldman or Natalya
RudmanCrescendo Communications, LLCEmail: mlss@crescendo-ir.comTel:
212-671-1020
Milestone Scientific (AMEX:MLSS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Milestone Scientific (AMEX:MLSS)
Historical Stock Chart
From Apr 2023 to Apr 2024